陈伶俐
简历：
教育背景:
1998.9-2002.6 中国药科大学 药物制剂 学士
2002.9-2005.6 中国药科大学 药剂学 硕士
工作经历:
2005.07 - 至今，在中国科学院上海药物研究所从事药物新型制剂的开发工作。
2018.10 - 至今，烟台药物研究所，特聘高级工程师。
工作业绩：
工作期间，主要从事抗肿瘤药物高端制剂的开发工作，承担并完成了10余个项目，已申报SFDA新药6项，获临床批件1项；申请专利34项，获得授权21项：参与发表论文
承担项目
1.完成了注射用多西他赛包合物的研发。通过包合技术和冻干工艺提高该药的水溶性 和稳定性，解决了市售普通注射剂易发生过敏反应的问题，提高了病人的顺应性。该项目已向SFDA申报，并已技术转让。
2.完成了注射用多西他赛的研发。在现有制剂基础上加以冻干处理，提高了药物的稳定性，大大延长了有效期，该项目已向SFDA申报。
3.完成了注射用多西他赛纳米粒的研发。利用脂质材料将多西他赛包裹制备成多西他赛纳米粒，通过纳米粒的被动靶向作用提高了药效，降低了毒性。通过冻干保护剂及冻干工艺的筛选和优化，攻克了纳米制剂冻干过程粒径增加、药物泄露的难题；通过冻干工艺解决了纳米制剂长期贮存稳定性差的问题；该项目已向SFDA申报，并已实现技术转让。
4.完成了注射用多西他赛脂质体的研发。利用脂质体制剂的优势将多西他赛包封于脂质双分子层，提高了药效，降低了毒性。采用乙醇注入法制备脂质体适应脂质体的工业化生产。
5.完成了多西他赛冻干乳剂的研发。本品是一种水包油纳米乳的冻干制剂，处方中不使用吐温80，消除了吐温80及糖皮质激素引起的不良反应，改善用药顺应性，并且采用冷冻干燥技术大大提高纳米乳的稳定性，延长有效期。该项目已向SFDA申报，并已实现技术转让。
6.完成了注射用前列地尔纳米粒的研发。将前列地尔包裹于脂质纳米粒中，大大提高了药物的稳定性，延长了有效期，与市售制剂相比，前列地尔纳米粒无刺激性和过敏反应，且给药剂量大大降低。该项目已向SFDA申报，并已实现技术转让。
7.完成了盐酸伊立替康复合脂质体的研发。利用两种磷脂材料制备成复合脂质体，提高了脂质体体内外稳定性，切向流超滤技术解决了该脂质体工业化生产的难题，与市售制剂比较，“优效性”极为显著，在耐药肿瘤和胰腺癌上的疗效提高6倍以上，毒副作用显著降低。该项目已向SFDA申报，已获临床批件，并已实现技术转让。
8.承担了SN38脂质体的开发工作。将脂难溶水难溶药物SN38包封于脂质体中，采用喷雾干燥结合高压均质、冷冻干燥技术制备而成。SN38脂质体能提高药物在血液中的稳定性，保持SN38的活性内酯环结构，通过脂质体的被动靶向作用，可以提高药效，降低毒性，有望填补SN38制剂的空白，为该药物的临床应用提供了可能。
申请专利：
1.陈伶俐 李亚平 钟涛 张丽.一种卡巴他赛磷脂组合物及其制备方法和应用
申请号：201610128739.X
2. 李亚平 陈伶俐 郑召磊 张志文 顾王文.一种盐酸伊立替康复合磷脂组合物、制备方法及其应用 申请号：201410085842.1
3. 李亚平 陈伶俐 郑召磊.一种酒石酸长春瑞滨长循环脂质体及其制备方法
申请号：201310567180.7
4. 李亚平 陈伶俐 樊继涛 张志文.一种多西他赛纳米胶束、其制备方法及应用
申请号：201310234505.X 有权
5. 李亚平 陈伶俐 樊继涛 顾王文 张志文.一种盐酸伊立替康组合物及其制备方法
申请号：201310055065.1 有权
6.李亚平 陈伶俐 樊继涛 顾王文 张志文.一种喹唑啉类分子靶向药物组合物
申请号：201210130265.4
7.李亚平 肖计生 陈伶俐 顾王文 张志文 高瑜. 一种能够自组装成胶束的多西他赛聚
氧乙烯-聚氧丙烯-聚氧乙烯化合物
申请号：201110170501.0 有权
8.肖计生 陈伶俐 顾王文 张志文 高瑜 李亚平.紫杉醇衍生物及其制备方法和用途
申请号：201110122969.2 有权
9.李亚平 张志文 黄彦 陈伶俐 顾王文.一种黄豆苷元胶束及其制备方法
申请号：200910198808.4 有权
10.李亚平 黄彦 张志文 陈伶俐 顾王文.一种黄豆苷元磷脂复合物及其制备方法
申请号：200910198807.X 有权
11.李亚平 陈伶俐 顾王文.多西他赛长循环固体脂质纳米粒及其制备方法
申请号：200810041865.7 有权
12.李亚平 陈伶俐 顾王文. 一种替尼泊甙药物组合物及其制备方法
申请号：200810040878.2
13.李亚平 陈伶俐 顾王文.福莫司汀固体脂质纳米粒及其制备方法
申请号：200810039089.7 有权
14.李亚平 陈伶俐 顾王文.替尼泊苷固体脂质纳米粒及其制备方法
申请号：200810038597.3
15.李亚平 陈伶俐 顾王文.依托泊苷固体脂质纳米粒及其制备方法
申请号：200810038114.X
16.李亚平 陈伶俐 顾王文.依托泊甙脂质体及其制备方法
申请号：200810037775.0
17.李亚平 陈伶俐 顾王文.替尼泊甙脂质体及其制备方法
申请号：200810037551.X 有权
18.李亚平 顾王文 陈伶俐.普萘洛尔或其盐的迟释制剂及其制备方法
申请号：200810033266.0 有权
19.李亚平 顾王文 陈伶俐.吡柔比星或盐酸吡柔比星脂质纳米粒及其制备方法
申请号：200710044137.7 有权
20.李亚平 顾王文 陈伶俐.多西他赛长循环制剂
申请号：200710041810.1 有权
21.李亚平 顾王文 陈伶俐.特布他林脉冲制剂及其制备方法
申请号：200710041684.X
22.李亚平 顾王文 陈伶俐.石杉碱甲及其衍生物或其盐的缓释纳米粒、和它的制造方法
申请号：200710038007.2 有权
23.李亚平 顾王文 陈伶俐.石杉碱甲及其衍生物或其盐的植入剂、其制备方法及应用
申请号：200710037550.0 有权
24.李亚平 顾王文 陈伶俐.盐酸克仑特罗双层缓释片及其制备方法
申请号：200710037549.8 有权
25.李亚平 顾王文 陈伶俐. 多奈哌齐类化合物长效缓控释组合物及其制备方法
申请号：200610117609.2 有权
26.李亚平 顾王文 陈伶俐.一种基因药物的输送系统及其制备方法
申请号：200610030849.9 有权
27.李亚平 陈伶俐 顾王文.注射用紫杉醇冻干乳剂及其制备方法
申请号：200610028554.8 有权
28.李亚平 陈伶俐 顾王文.注射用多西他赛冻干乳剂及其制备方法
申请号：200610028429.7
29.李亚平 陈伶俐 顾王文.前列地尔纳米粒及其制备方法
申请号：200610027594.0
30.李亚平 陈伶俐 顾王文.七叶皂苷钠冻干乳剂及其制备方法
申请号：200610027444.X 有权
31.李亚平 陈伶俐 顾王文.一种黄豆苷元药物组合物及其制备方法
申请号：200610025302.X
32.李亚平 陈伶俐 顾王文.一种含多烯紫杉醇类物质的药物组合物及其制备方法
申请号：200610023888.6 有权
33..李亚平 陈伶俐 顾王文.紫杉醇类物质固体脂质纳米粒及其制备方法
申请号：200510029633.6
34.李亚平 陈伶俐 顾王文.多烯紫杉醇脂质体及其制备方法
申请号：200510029634.0
发表文章：
9.Huiping Sun Jinghan Su Qingshuo Meng Qi Yin Lingli ChenWangwen Gu Pengcheng Zhang Zhiwen Zhang Haijun Yu Siling Wang Yaping Li .Cancer‐Cell‐Biomimetic Nanoparticles for Targeted Therapy of Homotypic Tumors.Advanced Materials 2016，28( 43)9581-88
10.Xinyu He Xiaoyue Bao Haiqiang Cao Zhiwen Zhang Qi Yin Wangwen Gu Lingli Chen Haijun Yu Yaping Li.Photothermal Therapy: Tumor‐Penetrating Nanotherapeutics Loading a Near‐Infrared Probe Inhibit Growth and Metastasis of Breast Cancer .Advanced Functional Materials2015 ,25(19)2940
11.Huiping Sun Jinghan Su Qingshuo Meng Qi Yin Lingli Chen Wangwen Gu Zhiwen Zhang Haijun Yu Pengcheng Zhang Siling Wang Yaping Li.Cancer Cell Membrane‐Coated Gold Nanocages with Hyperthermia‐Triggered Drug Release and Homotypic Target Inhibit Growth and Metastasis of Breast Cancer.Advanced Functional Materials2017, 27(3)：1604300
12.Xinyu He Xiaoyue Bao Haiqiang Cao Zhiwen Zhang Qi Yin Wangwen Gu Lingli Chen Haijun Yu Yaping Li.Tumor‐Penetrating Nanotherapeutics Loading a Near‐Infrared Probe Inhibit Growth and Metastasis of Breast Cancer.Advanced Functional Materials2015 ,25（19）2831-39
13.Shan Tang Qingshuo Meng Huiping Sun Jinghan Su Qi Yin Zhiwen Zhang Haijun Yu Lingli Chen Yi Chen Wangwen Gu Yaping Li.Tumor‐Microenvironment‐Adaptive Nanoparticles Codeliver Paclitaxel and siRNA to Inhibit Growth and Lung Metastasis of Breast Cancer.Advanced Functional Materials2016, 26（33）：6033-46
14.Shan Tang,Qingshuo Meng ,Huiping Sun , Jinghan Su,Qi Yin , Zhiwen Zhang, Haijun Yu , Lingli Chen, Wangwen Gu,Yaping Li .Dual pH-sensitive micelles with charge-switch for controlling cellular uptake and drug release to treat metastatic breast cancer.Biomaterials. 2017, 114:44-53
15.Huiping Sun, Qingshuo Meng,Shan Tang ,Jinghan Su ,Qi Yin ,Lingli Chen , Wangwen Gu , Haijun Yu,Zhiwen Zhang ,Siling Wang , Yaping Li.Inhibition of Breast Cancer Metastasis by Pluronic Copolymers with Moderate Hydrophilic-Lipophilic Balance.Mol Pharm. 2015 ,12(9):3323-31
16.Shan Tang , Qi Yin ,Jinghan Su , Huiping Sun,Qingshuo Meng ,Yi Chen ,Lingli Chen ,Yongzhuo Huang , Wangwen Gu ,Minghua Xu ,Haijun Yu ,Zhiwen Zhang ,Yaping Li .Inhibition of metastasis and growth of breast cancer by pH-sensitive poly (β-amino ester) nanoparticles co-delivering two siRNA and paclitaxel.Biomaterials. 2015 ,48:1-15
17.Shan Tang ,Qi Yin ,Zhiwen Zhang,Wangwen Gu,Lingli Chen , Haijun Yu, Yongzhuo Huang,Xianzhi Chen ,Minghua Xu ,Yaping Li .Co-delivery of doxorubicin and RNA using pH-sensitive poly (β-amino ester) nanoparticles for reversal of multidrug resistance of breast cancer.Biomaterials. 2014 ,35(23):6047-59
18.Jisheng Xiao ,Xiaopin Duan ,Qingshuo Meng ,Qi Yin ,Zhiwen Zhang ,Haijun Yu , Lingli Chen ,Wangwen Gu ,Yaping Li .Effective delivery of p65 shRNA by optimized Tween 85-polyethyleneimine conjugate for inhibition of tumor growth and lymphatic metastasis.Acta Biomater. 2014 Jun;10(6):2674-83
19.Qi Yin ,Jianan Shen ,Zhiwen Zhang ,Haijun Yu ,Lingli Chen ,Wangwen Gu ,Yaping Li .Multifunctional nanoparticles improve therapeutic effect for breast cancer by simultaneously antagonizing multiple mechanisms of multidrug resistance.Biomacromolecules. 2013 ,14(7):2242-52
20.Haijun Yu , Yonglong Zou , Lei Jiang, Qi Yin ,Xinyu He , Lingli Chen,Zhinwen Zhang ,Wangwen Gu , Yaping Li . Induction of apoptosis in non-small cell lung cancer by downregulation of MDM2 using pH-responsive PMPC-b-PDPA/siRNA complex nanoparticles.Biomaterials. 2013 ,34(11):2738-47
21.Zhiwen Zhang, Li Ma, Shijun Jiang, Zeying Liu, Jian Huang, Lingli Chen, Haijun Yu, Yaping Li.A self-assembled nanocarrier loading teniposide improves the oral delivery and drug concentration in tumor.J Control Release. 2013 , 28;166(1):30-7
22.Jianan Shen , Qi Yin, Lingli Chen, Zhiwen Zhang, Yaping Li.Co-delivery of paclitaxel and survivin shRNA by pluronic P85-PEI/TPGS complex nanoparticles to overcome drug resistance in lung cancer.Biomaterials. 2012 ,33(33):8613-24
23.Qi Yin,Jianan Shen ,Lingli Chen, Zhiwen Zhang, Wangwen Gu, Yaping Li.Overcoming multidrug resistance by co-delivery of Mdr-1 and survivin-targeting RNA with reduction-responsible cationic poly(β-amino esters).Biomaterials. 2012 ,33(27):6495-506
24.Jisheng Xiao, Xiaopin Duan, Qi Yin, Lingli Chen, Zhiwen Zhang, Yaping Li.Low molecular weight polyethylenimine-graft-Tween 85 for effective gene delivery: synthesis and in vitro characteristics.Bioconjug Chem. 2012 ,15;23(2):222-31
25.Yu Gao, Qi Yin, Lingli Chen, Zhiwen Zhang, Yaping Li.Linear cationic click polymers/DNA nanoparticles: in vitro structure-activity relationship and in vivo evaluation for gene delivery.Bioconjug Chem. 2011 , 15;22(6):1153-61
26.Yu Gao, Rongfu Yang, Zhiwen Zhang, Lingli Chen Zuyue Sun, Yaping Li.Solid lipid nanoparticles reduce systemic toxicity of docetaxel: performance and mechanism in animal.Nanotoxicology. 2011,5(4):636-49
27.Pengcheng Zhang , Lingli Chen , Zhiwen Zhang , Liping Lin , Yaping Li.Pharmacokinetics in rats and efficacy in murine ovarian cancer model for solid lipid nanoparticles loading docetaxel.J Nanosci Nanotechnol. 2010,10(11):7541-4.
28.Yu Gao, Lingli Chen, Zhiwen Zhang, Yi Chen, Yaping Li.Reversal of multidrug resistance by reduction-sensitive linear cationic click polymer/iMDR1-pDNA complex nanoparticles.Biomaterials. 2011 ,32(6):1738-47
29.Gao Yu, Lingli Chen, Zhiwen Zhang, Wangwen Gu, Yaping Li.Linear cationic click polymer for gene delivery: synthesis, biocompatibility, and in vitro transfection.Biomacromolecules. 2010 ,11(11):3102-11
30.Yongxin Yang, Zhiwen Zhang, Lingli Chen, Wangwen Gu, Yaping Li.Galactosylated poly(2-(2-aminoethyoxy)ethoxy)phosphazene/DNA complex nanoparticles: in vitro and in vivo evaluation for gene delivery.Biomacromolecules. 2010 Apr 12;11(4):927-33
31.Yongxin Yang, Zhiwen Zhang, Lingli Chen, Wangwen Gu, Yaping Li.Urocanic acid improves transfection efficiency of polyphosphazene with primary amino groups for gene delivery.Bioconjug Chem. 2010 Mar 17;21(3):419-26
32.Zhenghong Xu, Zhiwen Zhang, Yi Chen, Lingli Chen, Liping Lin, Yaping Li.The characteristics and performance of a multifunctional nanoassembly system for the co-delivery of docetaxel and iSur-pDNA in a mouse hepatocellular carcinoma model.Biomaterials. 2010 ,31(5):916-22
33.Yu Gao, Zhiwen Zhang, Lingli Chen, Wangwen Gu, Yaping Li.Synthesis of 6-N,N,N-trimethyltriazole chitosan via "click chemistry" and evaluation for gene delivery.Biomacromolecules. 2009 Aug 10;10(8):2175-82
34.Yu Gao, Lingli Chen, Wangwen Gu, Yong Xi, Liping Lin, Yaping Li.Targeted nanoassembly loaded with docetaxel improves intracellular drug delivery and efficacy in murine breast cancer model.Mol Pharm. 2008 ,5(6):1044-54
35.Zhenghong Xu, Lingli Chen, Wangwen Gu, Yu Gao, Liping Lin, Zhiwen Zhang, Yong Xi, Yaping Li. A smart nanoassembly consisting of acid-labile vinyl ether PEG-DOPE and protamine for gene delivery: preparation and in vitro transfection.Biomacromolecules. 2008 ,9(11):3119-26
36.Yu Gao, Wangwen Gu, Lingli Chen, Zhenghong Xu, Yaping Li.The role of daidzein-loaded sterically stabilized solid lipid nanoparticles in therapy for cardio-cerebrovascular diseases.Biomaterials. 2008 ,29(30):4129-36
37.Yongxin Yang, Zhenghong Xu, Jingui Jiang, Yu Gao, Wangwen Gu, Lingli Chen, Xiaozheng Tang, Yaping Li.Poly(imidazole/DMAEA)phosphazene/DNA self-assembled nanoparticles for gene delivery: synthesis and in vitro transfection. J Control Release. 2008,127(3):273-9
38.Yu Gao, Wangwen Gu, Lingli Chen, Zhenghong Xu, Yaping Li.A multifunctional nano device as non-viral vector for gene delivery: in vitro characteristics and transfection.J Control Release. 2007,118(3):381-8
39.Pengcheng Zhang, Lingli Chen, Wangwen Gu, Zhenghong Xu, Yu Gao, Yaping Li.In vitro and in vivo evaluation of donepezil-sustained release microparticles for the treatment of Alzheimer's disease.Biomaterials. 2007 ,28(10):1882-8
40.Wangwen Gu, Zhenghong Xu, Yu Gao, Lingli Chen, Yaping Li.Transferrin-mediated PEGylated nanoparticles for delivery of DNA/PLL.Nanotechnology. 2006,17(16):4148-55
所获奖励：
2016年 上海药物所年度考核“优秀”
2016年 获得上海药物所“技术能手”
2010年 上海药物所年度考核“优秀”
